Developer docs
API playgroundTry for free, no card

Search company profiles

Biosensing Instrument

Full company profile

uuid0007669

Namestring
Biosensing Instrument
Legal namestring
Biosensing Instrument Inc
Company typeenum
Private
Founded yearint
2003
Descriptiontext

Biosensing Instrument (legal name: Biosensing Instrument Inc) is a privately held scientific instrumentation company founded in 2003 by Arizona State University researchers and headquartered in Tempe, Arizona. The company designs, manufactures, and sells Surface Plasmon Resonance (SPR) instruments, with a distinctive technological lead in SPR Microscopy (SPRm), a method that combines optical microscopy with SPR to enable label-free, real-time measurement of molecular binding affinity and kinetics directly on whole cells in vitro. Its product portfolio includes the SPRm 220 Series cell-based SPR microscope (launched September 2025), the BI-4500 (5-channel) and BI-2500 (3-channel) benchtop SPR systems, interchangeable analysis modules for flow injection, electrochemical SPR, and gas-phase SPR, a range of proprietary sensor chips and accessories, and a cell-based bioanalytical measurement service for customers who want to outsource SPR experiments.

The company's primary customers are large pharmaceutical companies (Pfizer, AstraZeneca, Genentech, Ferring Pharmaceuticals) conducting drug discovery and membrane protein research, biotech companies focused on biologics development, and academic researchers. Pricing is quote-based with direct sales engagement, multi-year contract terms, and bundled consumables. The go-to-market motion is heavily event-driven: BI exhibits at major drug discovery and biophysics conferences (Discovery on Target, Drug Discovery Chemistry, BPS, NovAliX, AACR) where it offers one-on-one product demonstrations, supplemented by webinars, technical application notes, and direct inbound inquiries through biosensingusa.com.

Biosensing Instrument competes in a global SPR market projected to reach $2.3 billion by 2030 at an 11.5% CAGR. Its differentiation rests on the proprietary SPRm platform (first commercialized in 2017), the BI-DirectFlow module for near-zero-dispersion kinetic measurements, and over 20 years of EC-SPR publication history. The company has been recognized with the 2016 R&D 100 Award for the BI-4500/BI-2500 series and graduated from the Arizona Commerce Authority's Venture Ready Accelerator in 2020. It has no disclosed institutional funding, no public parent company, and operates with a small management team, making it a niche, founder-driven specialist vendor rather than a venture-backed growth company.

Short descriptiontext

Biosensing Instrument is a privately held Tempe, Arizona-based manufacturer of Surface Plasmon Resonance (SPR) and SPR Microscopy instruments used by pharmaceutical companies, biotech firms, and academic researchers for label-free molecular binding kinetics and drug discovery applications.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTempe, United States
HQ citystring
Tempe
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
surface plasmon resonance, SPR microscopy instruments, label-free binding analysis, kinetics measurement systems, cell-based bioanalytical tools
Industry2 codes
PRIMARYHLAGANAB
Proteomics & Mass Spectrometry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGAIAB
Mass Spectrometry & Spectroscopy Instruments
NAICS code1 code
  • Analytical Laboratory Instrument Manufacturing334516
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Scientific Instruments - Surface Plasmon Resonance (SPR) Systems
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1SPR Instrumentation Sales
TypeHardware Sales
Description

Sale of SPR instruments including SPRm 220 series for cell-based measurements, BI-4500 (5-channel) and BI-2500 (3-channel) benchtop SPR systems. Instruments are sold directly to pharmaceutical companies, biotech companies, and academic researchers.

biosensingusa.com
2Sensor Chips and Accessories
TypeHardware Sales
Description

Sale of various sensor chips (bare gold, divided gold, CM dextran, NI-NTA, streptavidin, Protein A, L1) and accessories including PP-100 automatic buffer exchange pump and BI-Autosampler.

biosensingusa.com
3Cell-based Bioanalytical Measurement Services
TypeProfessional Services
Description

Provides contract measurement services for pharmaceutical companies, biotech companies, and university researchers to measure direct on-cell binding interactions with simultaneous optical imaging. Delivers binding kinetics analysis reports and develops dose response methods.

biosensingusa.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Pricing details1 tier
1Quote-based pricing for instruments, accessories, and services
ModelOtherBilling cadenceMulti-year contract
Notes

Contact sales at info2BI@Biosensinginstrument.com for pricing inquiries on SPR instruments, sensor chips, and measurement services.

biosensingusa.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1BI-DirectFlow
Description

Flow injection analysis module technology included in BI-4500 series for near-zero dispersion sample delivery

biosensingusa.com
+1 more record
Core offering1 text field

Biosensing Instrument designs, manufactures, and sells Surface Plasmon Resonance (SPR) and SPR Microscopy (SPRM) instruments used to measure label-free, real-time molecular binding interactions for drug discovery and life science research. Its portfolio includes the SPRm 220 Series cell-based SPR microscopy system, the 5-channel BI-4500, and the 3-channel BI-2500 benchtop SPR systems, complemented by interchangeable Flow Injection, Electrochemical, and Gas Phase analysis modules, sensor chips and accessories, plus contract cell-based bioanalytical measurement services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Double throughput without compromising data quality with SPRm 220 series
+2 more records
Product overview1 text field

Biosensing Instrument offers a platform-plus-modules architecture centered on Surface Plasmon Resonance (SPR) technology for label-free molecular interaction analysis. The core product portfolio includes SPRm 220 Series (cell-based SPR microscopy for membrane proteins on whole cells), BI-4500 Series (5-channel high-throughput SPR with BI-DirectFlow), and BI-2500 Series (3-channel SPR for biosensor research). These instruments are complemented by interchangeable analysis modules for Flow Injection SPR, Electrochemical SPR (EC-SPR), and Gas Phase SPR applications. Accessories include various sensor chips (Bare Gold, CM Dextran, NI-NTA, Streptavidin, Protein A, L1), the BI-Autosampler, PP-100 buffer exchange pump, and SPRM Cell Chamber Sensor Kits. The company also provides cell-based bioanalytical measurement services for drug discovery research.

Product and service5 records
1SPRm 220 Series
CategoryCore SPR Instrument
Description

Cell-based Surface Plasmon Resonance Microscopy system that integrates optical microscopy and SPR for measuring binding affinity and kinetics of membrane proteins on whole cells in vitro, enabling simultaneous analysis of phenotypic changes via brightfield imaging and molecular interactions through SPR. Designed for pharmaceutical, biotech, and academic membrane protein research.

2BI-4500 Series
CategoryCore SPR Instrument
Description

5-channel SPR instrument with BI-DirectFlow technology for high-throughput assay development, featuring temperature-controlled SPR detection and compatibility with electrochemistry and chemical vapor analysis modules. Used for drug discovery and life science binding kinetics studies.

3BI-2500 Series
CategoryCore SPR Instrument
Description

3-channel benchtop SPR system preferred for advanced biosensor research including cancer biomarker detection, aptamer development, environmental monitoring, and food contamination analysis, with an open-design architecture supporting integrated electrochemistry and chemical vapor analysis modules.

4Cell-based Bioanalytical Measurement Services
CategoryMeasurement Services
Description

Contract cell-based binding assay services that measure direct on-cell binding interactions with simultaneous optical imaging, delivering binding kinetic profiles (KD, kon, koff), dose response methods, and assay optimization for pharmaceutical companies, biotech companies, and university researchers.

5Sensor Chips and Accessories
CategoryAccessories and Consumables
Description

Consumable product line including Bare Gold, Divided Gold, CM Dextran, NI-NTA, Streptavidin, Protein A, and L1 sensor chips for protein immobilization and liposome/vesicle work; the SPRM Cell Chamber Sensor Kit for cell-based SPRM; the BI-Autosampler for automated high-throughput sample delivery; and the PP-100 Automatic Buffer Exchange Pump with Degasser for multi-source buffer handling.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration with Associate Professor Shaopeng Wang from ASU's School of Biological and Health Systems Engineering to commercialize plasmonic imaging technologies for drug discovery and molecular diagnostics applications. The partnership leverages ASU's research expertise with BI's commercialization capabilities.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaborative poster presentation at AACR Annual Meeting 2026 on 'Integrated evaluation of payload-, Fc-, and target-mediated mechanisms of ADCs using streamlined complementary platforms'. Demonstrates interoperability of SPRm technology with Eurofins DiscoverX platforms.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Ongoing collaboration where Pfizer scientists present case studies using SPRm technology. Kris Borzilleri (Principal Scientist) presented on SPR Microscopy measures on-target binding kinetics for integral membrane proteins at NovAliX 2026. Pfizer has conducted multiple webinars and poster presentations showcasing SPRm applications.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dr. Niklas Larsson (Associate Principal Scientist) presented on applications of cell-based SPR microscopy at Drug Target Review webinar, showcasing receptor pharmacology studies on GPR39 and target engagement for membrane receptors.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Elaine Mai (Senior Scientific Researcher) presented on single cell label-free binding affinity applications, exploring avidities between monovalent and bivalent antibodies in correlation with cellular expression.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Dr. Marie-Laure Rives (formerly Director Pharmacology at Ferring, now at PostEra) presented on cell-based SPR microscopy application in drug discovery, reviewing case studies of small molecule pH-dependent binding of GPR4.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Cytiva's Biacore line is the gold-standard SPR instrument platform used across pharma and academic research; it is the primary direct competitor to Biosensing Instrument's BI-2500, BI-4500, and SPRm systems in label-free binding kinetics.

TypeDirect peer
Description

Reichert offers SPR-based binding analysis instruments and has been a long-standing competitor in the research-grade SPR market, directly comparable to BI's benchtop SPR product family.

TypeEmerging player
Description

Nicoya is a smaller specialty SPR / biosensor instrument company focused on benchtop, lower-cost label-free interaction analysis; it overlaps with BI's SPR product line, particularly for academic and biotech customers seeking accessible SPR.

TypeEmerging player
Description

Carterra provides high-throughput SPR-based antibody characterization and kinetics platforms; it targets similar pharma/biologics customers as BI with complementary SPR workflows.

TypeEmerging player
Description

Affinite Instruments builds label-free interaction analysis tools, including SPR-based platforms; it is a smaller emerging player competing for the same drug-discovery and academic research budget as BI.

TypeBroad incumbent
Description

Malvern Panalytical offers a broad portfolio of analytical instruments for biomolecular characterization (including MicroCal ITC and related label-free tools); it competes for the same biophysics and drug-discovery budget pool as BI's SPR systems.

TypeBroad incumbent
Description

Bruker is a large analytical instrumentation provider with products in biophysics and life-science research; while SPR is not its core focus, it competes for the same research-instrument capital budgets as BI in pharma and academic labs.

TypeBroad incumbent
Description

Agilent provides a broad portfolio of life-science and analytical instruments used in drug discovery and biopharma research; it is a broad incumbent that competes for the same instrument capital and consumables budgets as BI, though SPR is not its lead product line.

TypeBroad incumbent
Description

Horiba Scientific provides spectroscopy and surface analysis instrumentation, including optical sensor platforms relevant to SPR; it serves overlapping pharma, materials, and environmental research customers as BI.

TypeOthers
Description

Eurofins DiscoverX provides cell-based assay platforms for drug discovery and is a documented AACR 2026 collaboration partner of BI; while not an SPR competitor, it represents an adjacent/partner cell-based assay ecosystem relevant to BI's SPRM workflow.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biosensing Instrument

Scientific Instruments - Surface Plasmon Resonance (SPR) Systemsbiosensingusa.com

Biosensing Instrument is a privately held Tempe, Arizona-based manufacturer of Surface Plasmon Resonance (SPR) and SPR Microscopy instruments used by pharmaceutical companies, biotech firms, and academic researchers for label-free molecular binding kinetics and drug discovery applications.

What Biosensing Instrument does

Biosensing Instrument (legal name: Biosensing Instrument Inc) is a privately held scientific instrumentation company founded in 2003 by Arizona State University researchers and headquartered in Tempe, Arizona. The company designs, manufactures, and sells Surface Plasmon Resonance (SPR) instruments, with a distinctive technological lead in SPR Microscopy (SPRm), a method that combines optical microscopy with SPR to enable label-free, real-time measurement of molecular binding affinity and kinetics directly on whole cells in vitro. Its product portfolio includes the SPRm 220 Series cell-based SPR microscope (launched September 2025), the BI-4500 (5-channel) and BI-2500 (3-channel) benchtop SPR systems, interchangeable analysis modules for flow injection, electrochemical SPR, and gas-phase SPR, a range of proprietary sensor chips and accessories, and a cell-based bioanalytical measurement service for customers who want to outsource SPR experiments.

The company's primary customers are large pharmaceutical companies (Pfizer, AstraZeneca, Genentech, Ferring Pharmaceuticals) conducting drug discovery and membrane protein research, biotech companies focused on biologics development, and academic researchers. Pricing is quote-based with direct sales engagement, multi-year contract terms, and bundled consumables. The go-to-market motion is heavily event-driven: BI exhibits at major drug discovery and biophysics conferences (Discovery on Target, Drug Discovery Chemistry, BPS, NovAliX, AACR) where it offers one-on-one product demonstrations, supplemented by webinars, technical application notes, and direct inbound inquiries through biosensingusa.com.

Biosensing Instrument competes in a global SPR market projected to reach $2.3 billion by 2030 at an 11.5% CAGR. Its differentiation rests on the proprietary SPRm platform (first commercialized in 2017), the BI-DirectFlow module for near-zero-dispersion kinetic measurements, and over 20 years of EC-SPR publication history. The company has been recognized with the 2016 R&D 100 Award for the BI-4500/BI-2500 series and graduated from the Arizona Commerce Authority's Venture Ready Accelerator in 2020. It has no disclosed institutional funding, no public parent company, and operates with a small management team, making it a niche, founder-driven specialist vendor rather than a venture-backed growth company.

Biosensing Instrument firmographics

Firmographics
Name
Biosensing Instrument
Legal name
Biosensing Instrument Inc
Website
https://biosensingusa.com
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
11–50 employees
Short description
Biosensing Instrument is a privately held Tempe, Arizona-based manufacturer of Surface Plasmon Resonance (SPR) and SPR Microscopy instruments used by pharmaceutical companies, biotech firms, and academic researchers for label-free molecular binding kinetics and drug discovery applications.
Ownership category
akta.pro rank

Biosensing Instrument industry classification

Industry
Product category
Scientific Instruments - Surface Plasmon Resonance (SPR) Systems
NAICS
Analytical Laboratory Instrument Manufacturing (334516)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGANAB
Proteomics & Mass Spectrometry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGAIAB
Mass Spectrometry & Spectroscopy Instruments

Keywords

  • Surface plasmon resonance
  • SPR microscopy instruments
  • Label-free binding analysis
  • Kinetics measurement systems
  • Cell-based bioanalytical tools

Where Biosensing Instrument is headquartered

Location

Headquarters

HQ city
Tempe
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Biosensing Instrument business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. SPR Instrumentation Sales: Sale of SPR instruments including SPRm 220 series for cell-based measurements, BI-4500 (5-channel) and BI-2500 (3-channel) benchtop SPR systems. Instruments are sold directly to pharmaceutical companies, biotech companies, and academic researchers.
  2. Sensor Chips and Accessories: Sale of various sensor chips (bare gold, divided gold, CM dextran, NI-NTA, streptavidin, Protein A, L1) and accessories including PP-100 automatic buffer exchange pump and BI-Autosampler.
  3. Cell-based Bioanalytical Measurement Services: Provides contract measurement services for pharmaceutical companies, biotech companies, and university researchers to measure direct on-cell binding interactions with simultaneous optical imaging. Delivers binding kinetics analysis reports and develops dose response methods.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractQuote-based pricing for instruments, accessories, and services

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Biosensing Instrument product offering

Product offering

Core offering

Biosensing Instrument designs, manufactures, and sells Surface Plasmon Resonance (SPR) and SPR Microscopy (SPRM) instruments used to measure label-free, real-time molecular binding interactions for drug discovery and life science research. Its portfolio includes the SPRm 220 Series cell-based SPR microscopy system, the 5-channel BI-4500, and the 3-channel BI-2500 benchtop SPR systems, complemented by interchangeable Flow Injection, Electrochemical, and Gas Phase analysis modules, sensor chips and accessories, plus contract cell-based bioanalytical measurement services.

Product overview

Biosensing Instrument offers a platform-plus-modules architecture centered on Surface Plasmon Resonance (SPR) technology for label-free molecular interaction analysis. The core product portfolio includes SPRm 220 Series (cell-based SPR microscopy for membrane proteins on whole cells), BI-4500 Series (5-channel high-throughput SPR with BI-DirectFlow), and BI-2500 Series (3-channel SPR for biosensor research). These instruments are complemented by interchangeable analysis modules for Flow Injection SPR, Electrochemical SPR (EC-SPR), and Gas Phase SPR applications. Accessories include various sensor chips (Bare Gold, CM Dextran, NI-NTA, Streptavidin, Protein A, L1), the BI-Autosampler, PP-100 buffer exchange pump, and SPRM Cell Chamber Sensor Kits. The company also provides cell-based bioanalytical measurement services for drug discovery research.

Differentiator

Problem solved

Functional benefit

Brands

  • BI-DirectFlow: Flow injection analysis module technology included in BI-4500 series for near-zero dispersion sample delivery
  • EC-DualFlow

Products and services

  • SPRm 220 Series Cell-based Surface Plasmon Resonance Microscopy system that integrates optical microscopy and SPR for measuring binding affinity and kinetics of membrane proteins on whole cells in vitro, enabling simultaneous analysis of phenotypic changes via brightfield imaging and molecular interactions through SPR. Designed for pharmaceutical, biotech, and academic membrane protein research.
  • BI-4500 Series 5-channel SPR instrument with BI-DirectFlow technology for high-throughput assay development, featuring temperature-controlled SPR detection and compatibility with electrochemistry and chemical vapor analysis modules. Used for drug discovery and life science binding kinetics studies.
  • BI-2500 Series 3-channel benchtop SPR system preferred for advanced biosensor research including cancer biomarker detection, aptamer development, environmental monitoring, and food contamination analysis, with an open-design architecture supporting integrated electrochemistry and chemical vapor analysis modules.
  • Cell-based Bioanalytical Measurement Services Contract cell-based binding assay services that measure direct on-cell binding interactions with simultaneous optical imaging, delivering binding kinetic profiles (KD, kon, koff), dose response methods, and assay optimization for pharmaceutical companies, biotech companies, and university researchers.
  • Sensor Chips and Accessories Consumable product line including Bare Gold, Divided Gold, CM Dextran, NI-NTA, Streptavidin, Protein A, and L1 sensor chips for protein immobilization and liposome/vesicle work; the SPRM Cell Chamber Sensor Kit for cell-based SPRM; the BI-Autosampler for automated high-throughput sample delivery; and the PP-100 Automatic Buffer Exchange Pump with Degasser for multi-source buffer handling.

Quantifiable outcome

  • Double throughput without compromising data quality with SPRm 220 series
  • +2 more outcomes

Companies that use Biosensing Instrument

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Biosensing Instrument technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Biosensing Instrument partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • Arizona State UniversitycoreStrategic or Co-development PartnerCollaboration with Associate Professor Shaopeng Wang from ASU's School of Biological and Health Systems Engineering to commercialize plasmonic imaging technologies for drug discovery and molecular diagnostics applications. The partnership leverages ASU's research expertise with BI's commercialization capabilities.
  • Eurofins DiscoverXminorStrategic or Co-development PartnerCollaborative poster presentation at AACR Annual Meeting 2026 on 'Integrated evaluation of payload-, Fc-, and target-mediated mechanisms of ADCs using streamlined complementary platforms'. Demonstrates interoperability of SPRm technology with Eurofins DiscoverX platforms.
  • PfizercoreStrategic or Co-development PartnerOngoing collaboration where Pfizer scientists present case studies using SPRm technology. Kris Borzilleri (Principal Scientist) presented on SPR Microscopy measures on-target binding kinetics for integral membrane proteins at NovAliX 2026. Pfizer has conducted multiple webinars and poster presentations showcasing SPRm applications.
  • AstraZenecacoreStrategic or Co-development PartnerDr. Niklas Larsson (Associate Principal Scientist) presented on applications of cell-based SPR microscopy at Drug Target Review webinar, showcasing receptor pharmacology studies on GPR39 and target engagement for membrane receptors.
  • GenentechcoreStrategic or Co-development PartnerElaine Mai (Senior Scientific Researcher) presented on single cell label-free binding affinity applications, exploring avidities between monovalent and bivalent antibodies in correlation with cellular expression.
  • Ferring PharmaceuticalsminorStrategic or Co-development PartnerDr. Marie-Laure Rives (formerly Director Pharmacology at Ferring, now at PostEra) presented on cell-based SPR microscopy application in drug discovery, reviewing case studies of small molecule pH-dependent binding of GPR4.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Biosensing Instrument competitors and assessment

Company assessment

Direct peers

  • Cytiva (Biacore): Cytiva's Biacore line is the gold-standard SPR instrument platform used across pharma and academic research; it is the primary direct competitor to Biosensing Instrument's BI-2500, BI-4500, and SPRm systems in label-free binding kinetics.
  • Reichert Technologies: Reichert offers SPR-based binding analysis instruments and has been a long-standing competitor in the research-grade SPR market, directly comparable to BI's benchtop SPR product family.

Emerging players

  • Nicoya Lifesciences: Nicoya is a smaller specialty SPR / biosensor instrument company focused on benchtop, lower-cost label-free interaction analysis; it overlaps with BI's SPR product line, particularly for academic and biotech customers seeking accessible SPR.
  • Carterra: Carterra provides high-throughput SPR-based antibody characterization and kinetics platforms; it targets similar pharma/biologics customers as BI with complementary SPR workflows.
  • Affinite Instruments: Affinite Instruments builds label-free interaction analysis tools, including SPR-based platforms; it is a smaller emerging player competing for the same drug-discovery and academic research budget as BI.

Broad incumbents

  • Malvern Panalytical: Malvern Panalytical offers a broad portfolio of analytical instruments for biomolecular characterization (including MicroCal ITC and related label-free tools); it competes for the same biophysics and drug-discovery budget pool as BI's SPR systems.
  • Bruker: Bruker is a large analytical instrumentation provider with products in biophysics and life-science research; while SPR is not its core focus, it competes for the same research-instrument capital budgets as BI in pharma and academic labs.
  • Agilent Technologies: Agilent provides a broad portfolio of life-science and analytical instruments used in drug discovery and biopharma research; it is a broad incumbent that competes for the same instrument capital and consumables budgets as BI, though SPR is not its lead product line.
  • Horiba Scientific: Horiba Scientific provides spectroscopy and surface analysis instrumentation, including optical sensor platforms relevant to SPR; it serves overlapping pharma, materials, and environmental research customers as BI.

Others

  • Eurofins DiscoverX: Eurofins DiscoverX provides cell-based assay platforms for drug discovery and is a documented AACR 2026 collaboration partner of BI; while not an SPR competitor, it represents an adjacent/partner cell-based assay ecosystem relevant to BI's SPRM workflow.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key highlights6 records

Customer concentration

Biosensing Instrument social profiles

Digital presence

Biosensing Instrument financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biosensing Instrument leadership team

Management profile

Number of profiles

Profiles5 records

Biosensing Instrument funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biosensing Instrument M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biosensing Instrument

What does Biosensing Instrument do?

Biosensing Instrument designs, manufactures, and sells Surface Plasmon Resonance (SPR) and SPR Microscopy (SPRM) instruments used to measure label-free, real-time molecular binding interactions for drug discovery and life science research. Its portfolio includes the SPRm 220 Series cell-based SPR microscopy system, the 5-channel BI-4500, and the 3-channel BI-2500 benchtop SPR systems, complemented by interchangeable Flow Injection, Electrochemical, and Gas Phase analysis modules, sensor chips and accessories, plus contract cell-based bioanalytical measurement services.

Is Biosensing Instrument a public or private company?

Biosensing Instrument is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Biosensing Instrument founded?

Biosensing Instrument was founded in 2003. It employs 11 to 50 people.

Where is Biosensing Instrument based?

Biosensing Instrument is headquartered in Tempe, United States, in the North America region.

How does Biosensing Instrument make money?

Three revenue lines are on record. SPR Instrumentation Sales are the primary driver. The others are sensor Chips and Accessories and cell-based Bioanalytical Measurement Services.

Who are Biosensing Instrument's main competitors?

Direct peers on record are Cytiva (Biacore) and Reichert Technologies. Emerging players are Nicoya Lifesciences, Carterra and Affinite Instruments. Broad incumbents are Malvern Panalytical, Bruker, Agilent Technologies and Horiba Scientific. Eurofins DiscoverX is listed as an others.

Does Biosensing Instrument have an API?

No public API is recorded for Biosensing Instrument.

What industry is Biosensing Instrument in?

Biosensing Instrument's product category is Scientific Instruments - Surface Plasmon Resonance (SPR) Systems. Its primary akta.pro industry code is HLAGANAB, Proteomics & Mass Spectrometry Services, with a secondary code of HLAGAIAB, Mass Spectrometry & Spectroscopy Instruments. Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comMarket Trend Analysis: The Impact of Recent Innovations on the Surface Plasmon Resonance MarketThe surface plasmon resonance market is projected to reach $2.3 billion by 2030, growing at a compound annual growth rate of 11.5%, driven by increased applications in biologics, personalized medicine, and drug discovery. In October 2024, Bruker Corporation completed the acquisition of Dynamic Biosensors GmbH, a Germany-based biosensor technology company, to strengthen its portfolio in biophysical instruments. Additionally, U.S.-based Carterra introduced its LSA XT high-throughput SPR platform in February 2023, offering improved sensitivity and sample throughput for pharmaceutical and biotech companies.News-MedicalEngineering-driven startups at ASU advance biomedical innovationArizona State University's School of Biological and Health Systems Engineering is supporting biomedical innovation through faculty-led startup ventures, including ImmunoShield Therapeutics developing hydrogel-based cell-encapsulation technology, Sonoran Biosciences creating temperature-activated hydrogels for postoperative pain management, and Aneuvas Technologies working on injectable liquid technologies for vascular treatments. These ventures are supported by NIH Small Business Innovation Research and Small Business Technology Transfer funding, along with ASU's entrepreneurial programs like Venture Devils. The article profiles how the school's innovation ecosystem translates academic research into commercial medical technologies through both company formation and strategic industry partnerships like Shaopeng Wang's collaboration with Biosensing Instrument.NewswiseFrom Lab to Startup: ASU Researchers Drive Health InnovationArizona State University's School of Biological and Health Systems Engineering is highlighting how its innovation ecosystem supports biomedical researchers in translating academic discoveries into startup ventures. Three ventures are profiled: ImmunoShield Therapeutics, founded by Associate Professor Jessica Weaver to develop a hydrogel-based cell-encapsulation platform for protecting transplanted therapeutic cells from immune rejection; Sonoran Biosciences and Aneuvas Technologies Inc., both co-founded by Associate Professor Brent Vernon to address postoperative pain management and improve minimally invasive vascular treatments respectively; and a collaboration between Associate Professor Shaopeng Wang and Biosensing Instrument to develop plasmonic imaging technologies for drug discovery and molecular diagnostics. All ventures have received NIH Small Business Innovation Research or Small Business Technology Transfer funding, with ASU providing entrepreneurial support through programs like Venture Devils and Skysong Innovations.AsuFrom lab to startup: ASU researchers drive health innovationThree Arizona State University researchers have founded health-focused startup companies translating their academic lab work into commercial ventures, supported by NIH funding and ASU's innovation ecosystem. Associate Professor Jessica Weaver founded ImmunoShield Therapeutics to develop hydrogel-based cell-encapsulation technology protecting transplanted therapeutic cells from immune rejection, while Associate Professor Brent Vernon co-founded Sonoran Biosciences for temperature-activated postoperative pain management hydrogels and Aneuvas Technologies Inc. for injectable liquid technologies targeting vascular and neurovascular treatments. Additionally, Associate Professor Shaopeng Wang partnered with Biosensing Instrument to commercialize plasmonic imaging technologies for drug discovery and molecular diagnostics applications.PR NewswireSurface Plasmon Resonance (SPR) Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025Future Market Insights released a market report examining the global surface plasmon resonance (SPR) market for 2015-2025, covering market opportunities, key trends, drivers, and restraints for this technique used in drug development and proteomics. The SPR technique is gaining popularity due to its cost-effectiveness and high specificity compared to labeled detection methods, though growth is hampered by inadequate funding in developing countries and high product pricing. Key market players profiled include GE Healthcare, Bio-Rad Laboratories, Biosensing Instruments, Horiba Ltd., and Reichert Technologies (Ametek), with regional forecasts provided across North America, Europe, Latin America, Middle East & Africa, and Asia Pacific.PR NewswireSurface Plasmon Resonance (SPR) Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025Future Market Insights released a global Surface Plasmon Resonance market analysis covering the 2015–2025 period, examining market opportunities, key trends, drivers, and restraints for the SPR technique used in biomolecular interaction analysis for drug discovery and proteomics. The report profiles key market participants including GE Healthcare, Bio-Rad Laboratories, Biosensing Instruments, Horiba Ltd., and Reichert Technologies (acquired by Ametek). Key growth drivers identified include increasing adoption of label-free detection techniques due to cost effectiveness and specificity, while market restraints include inadequate funding in developing countries and high product pricing.PR NewswireSurface Plasmon Resonance (SPR) Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025Future Market Insights released a market research report on the Surface Plasmon Resonance (SPR) Market covering the 2015-2025 period, offering analysis of market opportunities, drivers, restraints, and segmentation by product, application, and region. The report profiles key industry participants including GE Healthcare, Bio-Rad Laboratories, Biosensing Instruments, Horiba Ltd., and Reichert Technologies (Ametek), analyzing their market presence and differentiators. The SPR market is driven by increasing adoption of label-free detection techniques in drug development and proteomics, though growth is constrained by inadequate funding in developing countries and high product pricing.